FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.